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Abstract
Background: Major bleeding is rare but among the most serious complications of laparoscopic surgery. Still very
little is known on bleeding complications and related blood component use in laparoscopic cholecystectomy (LC).
The aim of this study is to compare bleeding complications, transfusion rates and related costs between LC and
open cholecystectomy (OC).
Methods: Data concerning LCs and OCs and related blood component use between 2002 and 2007 were collected
from existing computerized medical records (Finnish Red Cross Register) of ten Finnish hospital districts.
Results: Register data included 17175 LCs and 4942 OCs. In the LC group, 1.3 % of the patients received red blood
cell (RBC) transfusion compared to 13 % of the patients in the OC group (p < 0.001). Similarly, the proportions of
patients with platelet (0.1 % vs. 1.2 %, p < 0.001) and fresh frozen plasma (FFP) products (0.5 % vs. 5.8 %) transfusions
were respectively higher in the OC group than in the LC group. The mean transfused dose of RBCs, PTLs and FFP
product Octaplas® or the mean cost of the transfused blood components did not differ significantly between the
LC and OC groups.
Conclusions: Laparoscopic cholecystectomy was associated with lower transfusion rates of blood components
compared to open surgery. The severity of bleeding complications may not differ substantially between LC and OC.
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Background
During the last two decades laparoscopic cholecystectomy
(LC) has become the golden standard of the treatment of
symptomatic gallbladder disease. Compared to the trad-
itional open cholecystectomy (OC), LC is associated with
lower morbidity [1] and mortality [2], shorter length of
hospital stay and faster return to normal activities [3].
However LC is associated with higher incidence of
iatrogenic bile duct injuries than OC [4–6].
Still, according to register studies, some 10 to 30 % of
all cholecystectomies are performed using open tech-
nique, particularly in elderly population [7] and in acute
cholecystitis [2, 8]. In addition, the open technique is
still needed, when the laparoscopic operation cannot be
completed safely and the conversion to open procedure is
required. According to the literature, current conversion
rate varies between 5 and 10 % [9–12]. The majority of
conversions are performed because of obscure anatomy
(difficult cholecystitis) or bleeding complications.
The incidence of bleeding complications requiring
transfusion or reoperation has been reported to be rela-
tively rare, occurring in 0.1 % in patients undergoing LC
[13]. Focus in the literature, however, has been on biliary
complications of LC. Yet, major vascular complications,
even though rare, are also serious complications of lapar-
oscopy [14, 15]. In addition, bleeding remains a frequent
reason for conversion [9, 10, 16, 17]. Regarding OC, only
few studies have reported the incidence of bleeding
complications in the laparoscopic era. Bleeding has been
reported to occur in 0.4 % of patients undergoing OC [4].
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There are very little data on transfusion rates of red
blood cells (RBCs) and hospital costs related to bleeding
in cholecystectomies.
The purpose of this study is to compare transfusion
rates, amounts of transfusions and related costs between
LC and OC in a large Finnish register-based cohort. No
prior data of blood transfusion and related costs in LC is
currently available.
Methods
Data from potentially transfused patients was collected
to a separate “Optimal Use of Blood” (VOK) registry in a
joint effort between the Finnish Red Cross Blood Service
and ten (out of 21) Finnish hospital districts. Five of the
hospital districts were teaching university-connected
hospital districts (C, F, G, I and J) and five central
hospital districts (A, B, D, E and H) (Fig. 1). The bleed-
ing registry was started in 2002 and continually updated
between 2002 and 2011, but the registry has been per-
manently terminated and erased in 2012. The data
collection system is described in more details by Palo
and co-workers [18]. Data were collected from hospitals
which fulfilled the technical prerequisites and could
deliver the required data. Altogether these hospital dis-
tricts have about 620 000 inpatient episodes annually,
constituting 63 % of all Finnish public inpatient hospital
episodes. Patient data came from pre-existing electronic
medical registers. Computer files provided information
on hospital admissions, diagnoses, surgical operations,
test results, and blood components as well as on transfu-
sions. The originally collected 90 transfusion-related var-
iables were processed and combined into 149 variables
to describe an episode. Systematic audit of data variable
was done [18].
For this study, patients who visited any study hos-
pital district for LC or OC between January 1st 2002
and December 31st 2007 were extracted from the ori-
ginal VOK registry (2002–2011). In this research regis-
try, data from the hospital district J is only available
from Jan 1st 2004 to December 31st 2007.
ICD-10 (International Statistical Classification of Dis-
eases and Related Health Problems, 10th Revision, 2003)
was used to categorize diagnoses. Surgical procedure was
defined according to the NCSP (The NOMESCO, Nordic
Medico-Statistical Committee, Classification of Surgical
Procedures) classification (NCSP–the NOMESCO Classi-
fication of Surgical Procedures version 1.7, 2005). All
patients over 15 years of age who underwent LC (JKA21)
or OC (JKA20) as a primary surgical procedure were
included in this study. NCSP does not have a separate
procedure code for conversion of LC converted into OC.
Thus, conversions cannot be identified from this data
and they are reported in the OC group. Cholecystecto-
mies associated with biliary or pancreatic neoplasms were
excluded based on the main diagnosis of the operation
and diagnoses for the hospital admission. All procedure
codes and diagnoses were set by treating physicians.
The following data was collected for each patient: age,
sex, American Society of Anaesthesiologists (ASA) class,
the main diagnosis, the primary surgical procedure, sec-
ondary surgical procedures, the status of the operation
(either elective/prescheduled or emergent/acute case),
the length of the operation, the usage of blood compo-
nents during the hospital stay, in-hospital mortality, the
length of hospital stay, the hospital, the hospital district
and reoperations performed within 60 days of the
cholecystectomy (not reported). Emergent operations
were performed mostly because of acute cholecystitis
or long-lasting painful biliary colic, which required hos-
pital admission. The recorded usage of blood components
included the number of transfused red blood cell (RBC)
units, number of transfused platelets (PLT), number of
transfused fresh frozen plasma products and the total cost
of the transfused blood components. The severity of acute
cholecystitis (flegmonous/perforated) was not included,
because no detailed operation files or pathological reports
from removed gallbladders were available.
The Finnish Red Cross Blood Service collects and dis-
tributes blood products from non-remunerated donors
nationwide in Finland [19]. Each RBC product is equiva-
lent of 1 unit. The PLT product was prepared using a
buffy-coat procedure and most of the transfused PLTs
were buffy-coat derived. The mean number of PLTs per
four-donor product was 296 × 109 and the volume was
about 320 ml [20]. Each PLT product is equivalent of (3-)4
units.
The fresh frozen plasma products consisted of fresh
frozen plasma (FFP) and Octaplas® (Octapharma Nordic
AB). The FFP refers to whole blood–recovered leukode-
pleted fresh plasma (volume, approximately 270 ml). One
product was equal to 1 unit of FFP [21]. During the study
period, Octaplas® was available in Finland from 2005 until
the end of the study. The usage of the FFP and Octaplas®
are presented separately in this study, because the unit
size and thus the amount of coagulation factors per unit
is smaller in Octaplas® compared to FFP.
The number of all cholecystectomies performed in
Finland in 2000–2007 was obtained from the National
Institute for Health and Welfare (NIHW) registry.
Permission to use the Bleeding registry data was ob-
tained from the institutional review board of the Finnish
Red Cross Blood Service. We did not use patients’ identifi-
cation details (name or social security number) in this
register study.
The aims and content of this study are in accordance
with the Helsinki Declaration. The respective ethics com-
mittee of the Finnish Red Cross Blood Service approved
the study protocol.
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The data was analyzed using IBM SPSS Statistics 22.0
(IBM, USA 2015). The independence of two categorical
variables was tested for with χ2 test. Mean values of
continuous variables were compared with either Student’s
t-test or Mann–Whitney U test where appropriate. Statis-
tical significance was defined as a p value less than 0.05.
Figure 1 Participated Finnish hospital districts
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Results
The total of 22 117 cholecystectomies comprise the final
data set for this study accounting for 43 % all cholecyst-
ectomies (51 094) performed in Finland in 2002–2007.
Of the included cholecystectomies, 78 % (17 175) were
LCs and 22 % (4942) were OCs. The number of LCs and
OCs by hospital district is shown in Fig. 2.
Demographic and perioperative data of the cholecyst-
ectomy patients is shown in Table 1. Compared to the
OC patients, the LC patients were younger, more often
female and more often belonged to the lower ASA clas-
ses. They also underwent an elective operation more
often than the OC patients (88 % vs. 38 %, p < 0.001).
The mean length of the operation was shorter for LCs
than for OCs. Intraoperative cholangiographies (IOC)
and common bile duct explorations were more common
in the OC group. In addition, the mean length of hospital
stay was longer and in-hospital mortality was higher
among the OC patients (2.5 % vs. 0.3 %, p > 0.001).
The blood component use associated with LC and OC
is shown in Table 2. Of the OC patients, as many as 16 %
of patients received transfusion of any blood component
compared to 1.6 % of the patients in the LC group. Simi-
larly, the proportions of patient with RBC (13 % vs. 1.3 %,
p < 0.001), PLT (1.2 % vs. 0.1 %, p < 0.001), FFP (4.9 % vs.
0.4 %, p < 0.001) and Octaplas® (0.9 % vs. 0.1 %, p < 0.001)
transfusions were respectively higher in OC group com-
pared to the LC group. Also the mean transfused dose of
the FFP was significantly higher in the OC group com-
pared to the LC groups. However, the mean transfused
dose of the other blood components and the mean cost of
the transfused blood components did not differ signifi-
cantly between the groups (Table 2).
Massive transfusion refers to the administration of ten
or more red blood cell units. In this cohort, 48 patients
(0.002 %) received massive transfusion. Demographic and
operative data of these patients is presented in Table 3.
The mean age of the massive transfusion patients were
48 years and 33 (69 %) of them were female. Most of the
cases (81 %) were related to OC and 72 % of the cases to
emergent operations. In addition to RBCs, 78 % of the
patients received fresh frozen plasma products (FFP or
Octoplas®) and 46 % PLTs. The massive transfusions were
associated with marked in-hospital mortality (15 %).
Discussion
According to the present study, OC is associated with
higher transfusion rate of blood components than LC. In
Figure 2 Number of laparoscopic cholecystectomies (LC) and open cholecystectomies (OC) by hospital districts in 2002 – 2007 (from hospital
district J data available only from 2004 to 2007)
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the current data, 13 % of the OC patients and 1.3 % of
LC patients received RBC transfusion. Also, for the other
blood component products (PLTs, FFP and Octaplas®),
the transfusion rates were significantly higher in the OC
group. In addition to more invasive nature of OC, this
may be partly due to the fact that the OC patients were
older and thus more likely to receive anticoagulant ther-
apy. The OC patients also underwent emergent operation
more often than LC patients.
The lack of systemic classification of bleeding complica-
tions in LC makes the comparison of the results of the
current study to the existing body of literature challen-
ging. Some authors have assessed and reported only
major vascular injuries (usually including injuries to the
aorta and its main branches, vena cava and the portal
vein), while life-threatening bleeding may also occur from
the liver bed [14]. Vascular injuries may also have been re-
ported as trocar injuries. Other authors have documented
bleeding requiring either transfusion or reoperation or
less serious intraoperative and postoperative bleeding.
Intraoperative and postoperative bleeding may have been
further divided into internal (peritoneal cavity of retro-
peritoneal space) and external (abdominal wall) bleeding
based on the localization.
The incidence of postoperative intra-abdominal bleed-
ing has been reported to be 0.69–1.05 % in LC patients
[9, 16]. In the analysis of 10 174 LCs by Z’graggen and
co-workers [9], bleeding was also the most frequent
intraoperative complication occurring in 1,97 % of the
cases. In a Finnish series of 1581 LCs, incidence of all
bleeding complications was 1.1 % [22] and bleeding com-
plications requiring reoperation occurred in 0.5 % of the
cases [23]. Roslyn and co-workers [4] reported the overall
incidence of bleeding complications of 0.4 % in the
analysis of 42 474 OCs. In their series, intraoperative
bleeding was also associated with a significant risk of
death. In the current study, the data on massive transfu-
sions indicates, that major bleeding remains a rare but
serious complication of cholecystectomy with significant
associated mortality. New advantages of technology, such
as ultrasonic dissection and anticoagulant pads may
decrease the bleeding complications in future register
studies.
Previous studies have hardly reported the need of
blood transfusion related to LCs and OCs. However, few
Table 1 Demographic and perioperative data of patients who
underwent open cholecystectomy (OC) or laparoscopic
cholecystectomy (LC) in 2002 – 2007
LC OC p











ASAa I 5842 (34.0) 673 (13.6) <0.001
II 6424 (38.0) 1564 (31.6) <0.001
III 2753 (16.0) 1756 (35.5) <0.001
IV 183 (1.1) 409 (8.3) <0.001






Mean operative time ± SD (min) 70 ± 37 99 ± 50 <0.001
Intraoperative cholangiography 862 (5.0) 1009 (20.0) <0.001
Common bile duct exploration 156 (0.9) 369 (7.5) <0.001
In-hospital mortality 59 (0.3) 122 (2.5) <0.001
Length of hospital stay ± SD (d) 2.8 ± 2.4 8.0 ± 4.7 <0.001
aASA American Society of Anaesthesiologists, SD Standard deviation
aData missing from 1974 patients in the LC group and 509 patients in the
OC group
bData missing from 43 patients
cData missing from 33 patients
Table 2 The use of blood components in open cholecystectomies (OC) and laparoscopic cholecystectomies (LC) in 2002–2007
LC OC p
n = 17175 (%) n = 4942 (%)
Proportion of patients with RBC transfusion 216 (1.3) 641 (13) <0.001
Mean transfused RBC dose (range) (unit) 3.4 (1 – 18) 3.6 (1 – 46) ns
Proportion of patients with PTL transfusion 15 (0.1) 59 (1.2) <0.001
Mean transfused PTL dose (range) (unit) 16 (4 – 48) 21 (3 – 104) ns
Proportion of patients with FFP transfusion 74 (0.4) 241 (4.9) <0.001
Mean transfused FFP dose (range) (unit) 3.2 (1 – 10) 4.3 (1 – 42) 0.008
Proportion of patients with Octaplas® transfusion 14 (0.1) 43 (0.9) <0.001
Mean transfused Octaplas® dose (range) (unit) 3.2 (1 – 12) 4.2 (1 – 15) ns
Proportion of patients with blood component transfusion 276 (1.6) 774 (16) <0.001
Mean cost of transfused blood components (range) (€) 284 (51 – 1310) 394 (51 – 10 607) ns
RBC Red blood cell, PTL Platelet, FFP Fresh frozen plasma, ns not significant
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publications reporting transfusion rates for general lap-
aroscopic operations exist. In their analysis of 14 243
general laparoscopic operations (of which 59.4 % were
LCs), Schäfer and co-workers [14] reported 33 patients
with intraoperative and 63 patients with postoperative
bleeding complications requiring blood transfusion. The
overall rate of bleeding complications requiring transfu-
sion was 0.7 % in their series, the overall rate of bleeding
complications (including minor bleeding such as lacer-
ation of minor vessels) being 4.1 %. Opitz and co-
workers [15] reported an overall bleeding rate of 3.3 % in
an LC-dominant (52 %) sample of 43 028 of general
laparoscopic operations. In their study, the higher trans-
fusion rate (24 %) was observed in patients with postop-
erative bleeding compared to patients with intraoperative
bleeding (7 %, p < 0.0001).
Transfusion rates for LC in this study, 1.3 % RBCs and
1.6 % for all blood component products, are higher than
reported for above mentioned LC-dominant general
laparoscopy samples [14, 15]. About 30 % of patients in
these two laparoscopy samples underwent herniotomy or
appendectomy, both procedures that do not involve the
dissection of the liver bed, a potent source of bleeding.
This may explain in part the higher observed transfusion
rate in this study. In addition, a previous report shows
that the rate of RBC usage in Finland has been rather
high compared to that in other European countries
partly, because the sufficient blood supply has not limited
the availability of blood component products and be-
cause of the low risk for transfusion-transmitted viral
infections in Finland [19].
Bleeding data of our transfusion register and particular
platelet transfusions in the patients undergoing general
surgery has been published earlier [20]. One-fourth
(27.1 %) of the surgery-related platelet transfusions went
to patients who had alimentary tract operations, 11 % in
orthopedic surgery, but mainly to patients undergoing
cardiac operations. Surgery-related bleeding complica-
tions and platelet transfusions occurred most frequently
between the age groups 50 and 79 years, and more
often in males than females [20]. In obstetric procedures,
platelets were used in 267/17916 (1.5 %) operations.
There are several limitations in this study. One is the
register-based nature of this study. First, the current data
covers only the transfusions associated with the hospital
stay during which the cholecystectomy took place, and
thus cases of delayed postoperative bleeding requiring
transfusion may have been missed. Second, reoperations
are not reported. Major bleeding is often defined as a
bleeding complication requiring transfusion or a reoper-
ation. However, there was a substantial number of miss-
ing diagnosis codes for 60-day reoperations in the data.
Combined with the lack of uniform practice for diagno-
sis and procedure code entries, when a complication
occurs, it would have been highly biased to report the
rate of reoperations, especially those performed because
of bleeding. Third, conversions could not be identified
from the data due to the lack of a separate procedure
code for conversion in NCSP. Consequently, cases of LC
converted into OC are included in the OC group in this
study. Since bleeding is a frequent reason for conversion
[9, 10, 16, 17], conversions would have been deserved to
be analyzed as a group of its own.
In addition, because of the register-based nature of this
study, patient-specific predisposing factors for bleeding
complications, such as anticoagulant or anti-platelet ther-
apy or liver cirrhosis, could not be identified from the
available data. A high incidence of post-operative bleeding
has been reported in patients on long-term anticoagulant
therapy undergoing LC, even when the anticoagulant ther-
apy was discontinued long enough for the international
normalized ratio to be normalized [24]. Additionally,
in a Swedish register study, systemic thromboprophy-
laxis increased the risk of bleeding complications in
LC, but the incidence of thromboembolic complication
was not significantly reduced [25]. On the other hand,
the association between anti-platelet therapy and bleeding
complications is controversial, especially in the case of
Table 3 Demographic and operative data, and the use of other
blood component products in patients who were administered
massive RBC transfusion (≥10 units)
Patients with massive
RBC transfusion
n = 48 (%)
Males/females 33/15 (69/31)
Mean age ± SD (range) 48 ± 16 (34 – 90)







Mean operative time ± SD (min) 122 ± 74
Intraoperative cholangiography 8 (17)
Common bile duct exploration 6 (13)
Proportion of patients with PTL transfusion 22 (46)
Proportion of patients with FFP transfusion 30 (63)
Proportion of patients with Octaplas® transfusion 7 (15)
In-hospital mortality 7 (15)
Length of hospital stay ± SD (d) 23 ± 14
ASA American Society of Anaesthesiologists, SD Standard deviation, RBC Red
blood cell, PTL Platelet, FFP Fresh frozen plasma
aData regarding ASA class missing from five patients
bData missing from one patient
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emergency surgery. In a recent retrospective case–control
study, long-term aspirin anti-platelet therapy was not
associated with increased risk of bleeding complications
in emergent LC for acute cholecystitis [26]. Based on the
results, the authors concluded that long-term aspirin use
should not be used as an independent factor to delay an
emergent LC. The impact of the new non-vitamin K
antagonist oral anticoagulants on the incidence of bleed-
ing complications associated with LC remains an interest-
ing topic for future research.
Conclusions
The present study shows that, in additions to other
virtues, LC is associated with lower transfusion rates of
RBCs, PLTs and FFP products compared to OC. The
mean transfused dose for RBCs, PLTs or Octaplas® and
the mean cost of transfused blood component products
per transfused patient did not differ significantly between
LCs and OCs indicating the severity of bleeding complica-
tion may not vary substantially between OC and LC.
Nevertheless, the observed higher transfusion rate in OC
increases the average costs of OC compared to LC.
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